Solar AD/CVD Orders Will Reach Cells for U.S. Module Assembly
The India, Indonesia and Laos solar cases cover cells bound for U.S. module plants, leaving buyers to weigh input duties against protection from imported panels.
Primary lensTrade remedies
Sub-topicAD/CVD orders
Evidence base5 records used
Use caseTrade-remedy exposure
The October 14 solar injury decision reaches an input that U.S. module factories buy as well as the finished panels they compete against. The USITC's affirmative determinations for India, Indonesia and Laos clear the way for antidumping and countervailing duty orders on crystalline silicon photovoltaic cells, including cells imported without modules. A U.S. assembly line does not remove that import exposure.
For a procurement manager choosing the plant's next cell contract, the result is a mixed form of protection. Duties can raise the cost of competing imported modules while also raising the plant's own input bill. The balance depends on where its cells are made, which producer supplies them and the import treatment applicable to each delivery. The injury finding alone cannot establish a factory's net gain.
The separate Section 232 program offers a potential route to import relief for approved investments in polysilicon, ingots, wafers and cells. Module assembly alone is outside that list, and the authorized relief does not erase AD/CVD. The immediate procurement decision is therefore about the cell supply behind a U.S. panel, not just the location of the final assembly line.
The imported cell remains within the case
Commerce's India final determination, including its written product scope, expressly includes qualifying parts for finished products assembled after importation. The scope covers cells whether or not they have already been assembled into modules, laminates, panels or other products. Importing covered cells for a U.S. module line therefore leaves a covered import transaction.
This is an existing scope boundary made more consequential by the final injury finding. Commerce said it had not modified the scope from initiation. The ITC did not announce a new country-of-origin rule on October 14.
A plant that already uses U.S.-produced cells has a different exposure from one importing covered cells from the three subject countries. Both can face competition from the same foreign modules, but only the latter supply route brings these cell imports into its cost calculation. The effect on each factory depends on its cell supply and the modules it competes with.
The product limits matter. The scope excludes specified thin-film technologies and narrowly defined products, and it excludes merchandise covered by certain existing solar orders. Those exclusions require a product and order match. They do not provide a general exemption for components destined for domestic manufacturing.
Moving module assembly does not move cell production
The Indonesia final CVD determination's Appendix I makes the geographic boundary explicit. Modules made in a third country from subject-country cells remain covered. Modules assembled in India, Indonesia or Laos using cells made outside all three countries are outside these investigations under that provision, which also appears in Commerce's Laos final scope. Other orders and trade measures still require a separate check.
That makes a supplier's assembly address an incomplete basis for approving a replacement source. A panel offered from a new country can retain the same cell exposure. A cell-factory change can alter the relevant scope analysis even when the module factory stays put.
The following comparison isolates these three-country AD/CVD cases. It assumes qualifying crystalline silicon products and no applicable exclusion.
Proposed supply route
Exposure under these cases
Evidence needed for the procurement comparison
Subject-country cells imported for U.S. module assembly
Covered cells are imported before assembly
Cell producer, factory location, exporter and applicable entry instructions
Subject-country cells assembled into modules elsewhere before U.S. import
Third-country assembly does not remove the modules from scope
Cell production records linked to the module shipment
Cells made outside India, Indonesia and Laos, assembled into modules in one of those countries
Outside these investigations under the stated cell-origin provision
Proof of cell production and a separate check of other solar orders
U.S.-produced cells assembled into modules domestically
No imported cell or module transaction under these cases
Traceability supporting the domestic cell supply claim
Compare the factory's input bill with the competing module
A tariff percentage by itself cannot show whether domestic assembly becomes more competitive. The plant's imported cells and a competitor's imported finished modules have different entered values. Procurement needs the duty dollars per usable watt for its cell supply, then assembly cost and yield, before comparing that result with a delivered module quote.
Producer selection also matters within a country. Commerce's Indonesian final determination assigns a 73.20 percent CVD rate to PT REC Solar Energy Indonesia and all others, and 173.70 percent to PT Blue Sky Solar Indonesia. These are CVD components, not complete landed-cost rates. Applying a country-wide headline percentage to every cell quote would conceal a material supplier difference.
Check the entry date as well as the supplier. The Indonesian final notice's suspension provisions describe the expired provisional-measures period and reinstatement following an affirmative injury determination. The vote itself is not a substitute for the operative publication and CBP instructions. Traverse's earlier analysis of solar rates and the cash-deposit gap explains that distinction. A purchase contract covering later deliveries needs both the current entry treatment and the order-stage exposure.
The onshoring incentive reaches further upstream
Proclamation 11052's onshoring provisions authorize Commerce to approve plans to build, refurbish or expand U.S. facilities producing raw polysilicon, ingots, wafers or cells. Approved plans can support imports of necessary production equipment and covered products without applicable Section 232 duties, in volumes commensurate with the investment. Benefits depend on construction progress and the approved plan.
A company with a module plant could invest in one of those upstream stages. Owning the module plant alone does not meet the stated production commitment. Nor does the proclamation give an approved company a general waiver from antidumping or countervailing duties. Clause 6(c) specifies Section 232 relief, while clause 5 preserves additional applicable duties.
This produces a further distinction between U.S. manufacturing plans. Moving assembly changes where labor and conversion costs occur. Adding cell production can also change reliance on imported cells and the eligibility analysis for the onshoring program. Neither an announced investment nor an application should be booked as approved tariff relief.
The next cell contract needs a documented source
Before accepting a revised cell quote, the procurement manager should obtain the producer and factory identity, records connecting the cells to the shipment, and the delivery-specific duty assumptions. If the supplier can substitute cell factories, the contract should make that change subject to a fresh cost and scope review.
For goods entered for consumption or withdrawn from warehouse for consumption on or after December 4, 2026, add the separate Section 232 calculation. The proclamation specifies different minimum import prices for cells and modules, and its documentation rule can reach the first arm's-length U.S. sale of downstream products. The two price floors are not a guaranteed assembly margin. The earlier Traverse analysis of the minimum-price sale record sets out that additional requirement.
Commerce's orders and CBP instructions will determine the next entry-stage treatment. A company-specific onshoring approval could change the Section 232 part of the calculation. The ITC says its public report will be available by November 23, providing the fuller injury record. Until those documents arrive, approve the cell source and its cost assumptions together.
Daily Trade Brief
Get the next one in your inbox.
New U.S. trade actions and the analysis that changes an import, customs, or counsel file, on weekday mornings after you confirm your address.
From reading to review
Run the numbers on your lane.
The duty calculator runs the current stack for any HTS code and origin. A free account opens full tool output, AD/CVD detail, Chapter 98 processing, and available exports.